Ruxolitinib/Selinexor Combo Is Being Evaluated for Multiple Myeloma:
Ruxolitinib Elicits Few Adverse Effects When Treating Multiple Myeloma:
Ruxolitinib Is Under Investigation as JAK Inhibition Strategy for Multiple Myeloma:
Exploring the Potential Role of JAK Inhibitors in Multiple Myeloma:
The Exciting Launch of Myeloma BioBank:
James R. Berenson, MD, Multiple Myeloma, specialist announced in an interview on Blood Cancers Today the exciting launch of a new company, Myeloma BioBank, which will offer blood and bone marrow samples for purchase. All proceeds will support myeloma research. Dr. Berenson’s informative interview: www.bloodcancerstoday.com/post/dr-berenson-on-the-myeloma-biobank-launch.
- Myeloma BioBank: www.myelomabiobank.com
Targeted Oncology:
Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients.
- Reference: James R. Berenson, MD Berenson Cancer Center
Article
American Society of Hematology:
Blood Journal: A Phase 1 Trial: Evaluating…Methylprednisolone: RE: ASH 2023 San Diego, CA December 9-11 Media Interviews Summary on: Phase 1 Study and others BLOOD is a very important medical journal.
Article
MedPage Today:
James R. Berenson, MD: Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma? Early-phase experience with ruxolitinib suggests potential role in relapsed/refractory disease
Video
HemOnc Today:
Multiple Myeloma regimens significantly less effective in real-world treatment settings
PERSPECTIVE – James R. Berenson, MD.
Article
Healio Hematology & Oncology News:
Interviewed Dr. Berenson on his perspective on Abstract 1 & Abstract 2.
Questions: Reaction to results — anything surprising? Most important take home message or clinical implication.
Has built many patient programs and over 8 integrated software platforms to help blood cancer patients learn more about their disease and better navigate their disease. Interviewed Dr. Berenson on phase 1 data and others.
- Outcomes of Triple Class Refractory Multiple Myeloma Patients | James Berenson, MD | ASH 2023
Video - Medical Writing Bias in Myeloma Clinical Research | James Berenson, MD | ASH 2023
Video - Assessing Lenalidomide with Patients Progressing on JAK Inhibitors | James Berenson, MD | ASH 2023
Video
VJHemOnc: (The Video Journal of Hematological Oncology) is an open-access video journal dedicated to providing trusted and up-to-date medical information to improve understanding of hematological cancers. Interviewed Dr. Berenson on phase 1 data and other ASH news.
- Dr. Berenson’s interviews from ASH are now live and can be found here: Videos
OncologyTube: James R. Berenson, MD
Article
Benefits of MRD Testing for the Treatment of Patients With Multiple Myeloma
Article
More Interviews & Videos
Dinner with the Docs – James R. Berenson, MD – Southern California
- First-Line Treatment Options & Side Effects – Video
- Advances in Treating Relapsed Multiple Myeloma – Video
- How Are Clinical Trials for Multiple Myeloma Structured? – Video
The New York Times:
What Scientists Know About the Risk of Breakthrough Covid Deaths
Article
CBS News:
Myeloma may have made Colin Powell more vulnerable to dying of COVID-19 despite vaccination
Article
Scientific America:
How Immunocompromised People Without Strong Vaccine Protection Are Coping with COVID
Article
Myeloma Today:
Responses to mRNA COVID-19 Vaccines in MM Patients
Article
BuzzFeed News:
Colin Powell: The First Black Secretary Of State, Has Died Of COVID Complications
Article
VOAN NEWS:
Mandates Give Rise to Booming Black Market for Fake Vaccine Cards
Article
Eat This, Not That!
Article
TV Interviews
KTTV June 10, 2021
KNBC June 14, 2021
KCAL June 14, 2021
KTTV June 10, 2021
Drugs Used for Myeloma are Helping Fight COVID-19
Several anti-inflammatory drugs used to treat multiple myeloma are showing promising results treating Covid-19. Video
CAN DIET AND SUPPLEMENTS PREVENT SMOLDERING MYELOMA FROM PROGRESSING
Is there a proven diet that can keep smoldering myeloma from progressing? What about fasting and taking supplements? What do the experts recommend? Video
DOES SMOLDERING MYELOMA TREATMENT NEED TO BE AGGRESSIVE?
Smoldering myeloma happens when changes in the blood are caught early in a blood test and is a precursor to multiple myeloma. What is it like living with smoldering myeloma and how aggressively should you be monitored and treated? Video
LYMPHOMA & MYELOMA CONGRESS NYC OCTOBER 2019: PREDICTING PATIENT OUTCOMES WITH MM USING SERUM B-CELL MATURATION ANTIGEN:
New York—In a presentation at the 2019 Lymphoma & Myeloma congress, James R. Berenson, MD, Medical and Scientific Director, Institute for Myeloma and Bone Cancer Research, West Hollywood, California, spoke about the use of serum B-cell maturation antigen (sBCMA) to predict outcomes in patients with multiple myeloma (MM). Video
